INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 131 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $266 | -73.4% | 480 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | – | 480 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 480 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 480 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | -50.0% | 480 | 0.0% | 0.00% | – |
| Q3 2021 | $2,000 | +100.0% | 480 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | -50.0% | 480 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | +100.0% | 480 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | – | 480 | +42.9% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 336 | -3.7% | 0.00% | – |
| Q1 2016 | $2,000 | -89.5% | 349 | -85.1% | 0.00% | – |
| Q4 2015 | $19,000 | +533.3% | 2,337 | +593.5% | 0.00% | – |
| Q3 2015 | $3,000 | -88.5% | 337 | -85.5% | 0.00% | – |
| Q2 2015 | $26,000 | -13.3% | 2,326 | +6.8% | 0.00% | – |
| Q1 2015 | $30,000 | -18.9% | 2,177 | +0.2% | 0.00% | – |
| Q4 2014 | $37,000 | – | 2,173 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 7,866,108 | $25,408,000 | 4.32% |
| Nine Chapters Capital Management LLC | 91,500 | $296,000 | 0.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,969,225 | $6,361,000 | 0.24% |
| Orbimed Advisors | 3,250,300 | $10,498,000 | 0.12% |
| PINNACLE ASSOCIATES LTD | 1,306,679 | $4,221,000 | 0.08% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 810,232 | $2,617,000 | 0.07% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 270,417 | $873,000 | 0.06% |
| Rock Springs Capital Management LP | 270,000 | $872,000 | 0.05% |
| ALGERT GLOBAL LLC | 39,876 | $129,000 | 0.04% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 391,671 | $1,265,000 | 0.03% |